References
- Therapeutic Goods Administration. Orphan drugs program discussion paper. Australian Government. 2015.
- Cancer Council Australia and Clinical Oncology Society of Australia submission of the orphan drugs review. Submitted 13/3/15. [ cited 2016 Apr 20].
- Phillips MI. Big Pharma’s new model in orphan drugs and rare diseases. Expert Opinion Orphan Drugs. 2013;1:1–3.